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Introduction {#sec1}
============

Epithelial integrity and tissue homeostasis are severely challenged by wounding or a range of pathological states. Under such conditions, epithelial cells can detach from the underlying basement membrane and undergo apoptotic cell death through a process known as anoikis ([@bib5], [@bib9], [@bib10], [@bib32]). Subsequently, the missing epithelial cells can be replaced through the activity of endogenous stem/progenitor cells. In the prostate, insults such as bacterial or viral infection can result in inflammation and epithelial cell death, but the process of repair has been poorly studied to date.

The identity of epithelial stem/progenitor cells within the prostate remains a subject of intense study ([@bib29]). The prostate epithelium comprises luminal, basal, and neuroendocrine cells, with both luminal and basal compartments containing stem/progenitor activity ([@bib27]). In addition, rare "intermediate" cells that co-express basal and luminal markers have been proposed to correspond to stem/progenitor cells ([@bib8], [@bib36], [@bib37], [@bib43]), or a transitional state between basal progenitors and luminal descendants ([@bib2], [@bib20], [@bib23], [@bib35]).

Stem/progenitor activity has been observed in distinct contexts during prostate development and homeostasis in vivo. In the hormonally naive adult prostate epithelium, luminal and basal compartments are maintained by unipotent progenitors ([@bib6], [@bib22], [@bib39]), while during prostate organogenesis some basal progenitors are multipotent, giving rise to luminal and neuroendocrine progeny ([@bib23], [@bib40]). In addition, rare bipotential populations exist within both the luminal and basal compartments during androgen-mediated regeneration of the regressed prostate ([@bib19], [@bib38], [@bib39], [@bib42]).

In contrast, both luminal and basal populations display considerable lineage plasticity in specific contexts. Explanted luminal cells can generate basal cells in organoid culture ([@bib7], [@bib15]), whereas basal cells can generate luminal cells in sphere formation assays, and after recombination with embryonic urogenital mesenchyme in renal grafts ([@bib4], [@bib11], [@bib12], [@bib13], [@bib18], [@bib25], [@bib39]). Basal-to-luminal differentiation can also occur in pathological contexts, such as during prostate cancer initiation ([@bib6], [@bib22], [@bib39], [@bib41]), and after acute inflammation in bacterial prostatitis ([@bib17]).

Taken together, these findings indicate that basal-to-luminal differentiation can occur in prostate organogenesis, pathogenesis, and ex vivo assays, but rarely during normal tissue homeostasis. Thus, it has been unclear to what extent the plasticity of endogenous adult prostate basal cells in ex vivo models and disease states reflects an in vivo activity. In this study, we introduce a mouse model in which a tamoxifen-inducible Cre driver is used to delete E-cadherin in prostatic luminal cells, which are highly susceptible to anoikis ([@bib16]). This results in rapid sloughing and death of luminal cells, followed by repair of the damaged epithelium. We show that basal-to-luminal differentiation contributes to tissue repair, providing a new approach for studying prostate stem/progenitor activity and epithelial specification.

Results {#sec2}
=======

E-Cadherin Is Essential for Maintenance of Prostate Luminal Cells {#sec2.1}
-----------------------------------------------------------------

To delete *E-cadherin* (*Cdh1*) in the prostate epithelium, we used mice carrying the tamoxifen-inducible *Nkx3.1*^*CreERT2*^ driver ([@bib38]), the conditional *Cdh1*^*flox*^ allele ([@bib3]), and an *R26R-YFP* reporter ([@bib31]). We administered tamoxifen to *Nkx3.1*^*CreERT2/+\ or\ CreERT2/CreERT2*^; *Cdh1*^*flox/flox*^; *R26R-YFP* (designated *Cdh1*^*del*^) mice at 8 weeks of age, and analyzed prostate tissues at 5, 9, 14, 20, and 30 days thereafter ([Figure 1](#fig1){ref-type="fig"}A). In parallel, control *Nkx3.1*^*CreERT2/+*^; *R26R-YFP* mice were treated with tamoxifen and analyzed at 5, 14, and 30 days later.

Histological analyses of the anterior prostate lobes showed that controls maintained a normal phenotype after tamoxifen treatment ([Figures 1](#fig1){ref-type="fig"}B, [S1](#mmc1){ref-type="supplementary-material"}A, and S1B), whereas *Cdh1*^*del*^ prostates underwent epithelial damage and repair. At 5 days after tamoxifen administration, we observed foci of atypical cells in *Cdh1*^*del*^ prostates ([Figure 1](#fig1){ref-type="fig"}C), and at 9 and 14 days after tamoxifen treatment, many cells had detached from the epithelium and were present in the lumen ([Figures 1](#fig1){ref-type="fig"}D and 1E). However, by 20 days after treatment, fewer detached cells were observed, and at 30 days the normal epithelial phenotype was restored ([Figures 1](#fig1){ref-type="fig"}F and 1G). Similar results were observed in the ventral prostate (VP) and dorsolateral prostate (DLP) of control and *Cdh1*^*del*^ mice ([Figure S2](#mmc1){ref-type="supplementary-material"}).

To confirm these phenotypes were due to E-cadherin deletion, we analyzed co-expression of E-cadherin and YFP by immunofluorescence staining of control and *Cdh1*^*del*^ prostates. In control prostates, E-cadherin displayed intact membrane localization in YFP^+^ cells ([Figures 1](#fig1){ref-type="fig"}H, [S1](#mmc1){ref-type="supplementary-material"}C, and S1D). However, YFP^+^ cells in *Cdh1*^*del*^ mice started to lose E-cadherin expression by 5 days after tamoxifen treatment ([Figure 1](#fig1){ref-type="fig"}I), and was lost in 93% of YFP^+^ cells at 9 days ([Figure 1](#fig1){ref-type="fig"}J and [Table S1](#mmc1){ref-type="supplementary-material"}). Moreover, the detached cells in the prostate lumen of *Cdh1*^*del*^ mice at 14 and 20 days after treatment expressed YFP, but not E-cadherin ([Figures 1](#fig1){ref-type="fig"}K and 1L). In contrast, by 30 days the epithelium displayed a normal distribution of membrane-localized E-cadherin, but YFP^+^ cells were nearly absent ([Figure 1](#fig1){ref-type="fig"}M). Notably, the few remaining YFP^+^ cells were localized to basal positions, comprising approximately 2% of the prostate epithelium ([Figure 1](#fig1){ref-type="fig"}M and [Table S2](#mmc1){ref-type="supplementary-material"}).

To confirm deletion of E-cadherin we also examined expression of p120 catenin, a binding partner of E-cadherin that becomes localized to the cytoplasm following loss of E-cadherin ([@bib28]). Consistent with E-cadherin expression, control prostates displayed normal membrane localization of p120 catenin ([Figures 1](#fig1){ref-type="fig"}N, [S1](#mmc1){ref-type="supplementary-material"}E, and S1F), whereas *Cdh1*^*del*^ prostates at 5 days after tamoxifen treatment contained sporadic luminal cells with increased cytoplasmic localization of p120 ([Figure 1](#fig1){ref-type="fig"}O). At 9 and 14 days, numerous luminal cells showed strong cytoplasmic localization of p120 ([Figures 1](#fig1){ref-type="fig"}P and 1Q), which were reduced in frequency at 20 days ([Figure 1](#fig1){ref-type="fig"}R). By 30 days, the *Cdh1*^*del*^ prostates showed essentially normal p120 expression, with rare cells that displayed cytoplasmic p120 localization still detectable ([Figure 1](#fig1){ref-type="fig"}S).

E-Cadherin Deletion in Luminal Cells Results in Anoikis Followed by Rapid Epithelial Repair {#sec2.2}
-------------------------------------------------------------------------------------------

We anticipated that E-cadherin deletion would be limited to the luminal compartment in *Cdh1*^*del*^ prostates, since the *Nkx3.1*^*CreERT2*^ driver is mostly restricted to luminal cells ([@bib38]). To examine the specificity of E-cadherin deletion, we compared expression of YFP with specific luminal and basal markers in control and *Cdh1*^*del*^ prostates at the most prominent stage of epithelial damage (14 days), and after repair (30 days). As expected, YFP expression was predominantly observed in CK18-positive luminal cells of control mice at 30 days (34.9% of CK18^+^ cells versus 0.7% of CK5^+^ cells) ([Figure 2](#fig2){ref-type="fig"}A and [Table S3](#mmc1){ref-type="supplementary-material"}). In *Cdh1*^*del*^ prostates, the detached YFP^+^E-cadherin^--^ cells in the prostate lumen at 14 days were also CK18^+^ ([Figure 2](#fig2){ref-type="fig"}B), confirming that these sloughed cells were luminal. Notably, at 30 days the *Cdh1*^*del*^ luminal cells displayed membrane-localized E-cadherin but were YFP^--^ ([Figure 2](#fig2){ref-type="fig"}C), indicating replacement of sloughed luminal cells by newly formed luminal cells.

However, at 30 days we observed rare surviving YFP^+^ cells that occupied basal positions, but did not resemble normal basal cells ([Figure 2](#fig2){ref-type="fig"}C); these may correspond to *Cdh1* null luminal cells that survived due to their ectopic localization. Consistent with this interpretation, these residual YFP^+^ cells were mostly negative for the basal marker CK5 ([Figures 2](#fig2){ref-type="fig"}D--2F and [S3](#mmc1){ref-type="supplementary-material"}A; [Table S2](#mmc1){ref-type="supplementary-material"}). Furthermore, the residual YFP^+^ cells were rarely intermediate (CK5^+^CK8^+^), did not express the neuroendocrine marker synaptophysin, and did not express N-cadherin, suggesting that they were not undergoing an epithelial-mesenchymal transition ([Figures S3](#mmc1){ref-type="supplementary-material"}B--S3D and [Table S2](#mmc1){ref-type="supplementary-material"}).

Since deletion of E-cadherin resulted in sloughing of luminal cells, we examined whether these cells underwent anoikis. We found that the apoptotic marker cleaved caspase-3 (CC3) was rarely detected in control or *Cdh1*^*del*^ prostates at 30 days, but was readily detectable in the detached luminal cells of *Cdh1*^*del*^ prostates at 14 days ([Figures 2](#fig2){ref-type="fig"}G--2I). Taken together, these data indicate that E-cadherin is essential for survival of luminal epithelial cells, and the *Cdh1*^*del*^ mice provide a model for studying anoikis and epithelial repair in the prostate.

Loss of E-Cadherin in Prostate Luminal Cells Does Not Affect the Surrounding Stroma {#sec2.3}
-----------------------------------------------------------------------------------

Since another model of prostate epithelial repair has suggested a role for reactive stroma ([@bib17]), we examined whether epithelial deletion of E-cadherin might result in stromal defects. Previous studies have characterized reactive stroma as displaying loss of smooth muscle-expressing α-actin and an increase in fibroblasts that express vimentin ([@bib17], [@bib33], [@bib34]). Therefore, we compared the expression of smooth muscle α-actin (SMA) and vimentin in control and *Cdh1*^*del*^ prostates. Immunostaining of SMA in control and *Cdh1*^*del*^ prostates showed continuous smooth muscle bands surrounding the epithelial ducts, with no loss of smooth muscle organization ([Figures 2](#fig2){ref-type="fig"}J--2L). In addition, we did not observe an increase in vimentin staining in the stroma of *Cdh1*^*del*^ mice ([Figures 2](#fig2){ref-type="fig"}M--2O), indicating that the process of epithelial repair occurs without a phenotypically reactive stroma.

Prostate Basal Cells Contribute to Epithelial Repair after E-Cadherin Deletion in Luminal Cells {#sec2.4}
-----------------------------------------------------------------------------------------------

Next, we investigated the cell type(s) that were responsible for epithelial repair in *Cdh1*^*del*^ prostates. First, we quantitated the proportion of basal (CK5^+^), luminal (CK8^+^), and intermediate (CK5^+^CK8^+^) cells during tissue repair ([Table S4](#mmc1){ref-type="supplementary-material"}). We found that the proportions of basal and luminal cells showed a significant increase and decrease respectively, by 14 days, which then revert to normal proportions by 30 days ([Figures 3](#fig3){ref-type="fig"}A--3F, 3M, and 3N). Notably, while control prostates contained only rare intermediate cells, *Cdh1*^*del*^ prostates showed increasing proportions of intermediate cells by 14 days, which subsequently decreased to normal levels by 30 days ([Figures 3](#fig3){ref-type="fig"}A--3F and 3O). Interestingly, we observed intermediate cells appearing to emerge from the basal layer at 9 days ([Figure 3](#fig3){ref-type="fig"}C).

Second, we determined the percentages of proliferating and detaching (dying) cells in the basal and luminal compartments ([Table S5](#mmc1){ref-type="supplementary-material"}). In control prostates, there was limited epithelial proliferation that primarily occurred in the luminal compartment ([Figures 3](#fig3){ref-type="fig"}G and 3P). However, in *Cdh1*^*del*^ prostates, CK5^+^ basal cells showed significantly increased proliferation at 9 and 14 days, before decreasing to control levels ([Figures 3](#fig3){ref-type="fig"}H--3L and 3P), while little cell death in basal cells was detected at any time point ([Figure 3](#fig3){ref-type="fig"}Q). We also found increased proliferation of luminal cells at later time points (14 and 20 days), before decreasing to control levels ([Figures 3](#fig3){ref-type="fig"}H--3L and 3P). Notably, cell death as indicated by detachment into the lumen was only detectable for CK8^+^ luminal cells, and was most significant at 14 days ([Figure 3](#fig3){ref-type="fig"}Q).

Since the proportion of basal cells returned to normal levels by 30 days, and few if any basal cells underwent anoikis ([Figures 3](#fig3){ref-type="fig"}M and 3Q), the increased proliferation of basal cells observed by 9 days ([Figure 3](#fig3){ref-type="fig"}P) indicates that basal cells contribute to repair of the luminal compartment. This interpretation is also consistent with the transient increase in the percentage of intermediate cells at 14 days ([Figure 3](#fig3){ref-type="fig"}O). Thus, our findings suggest that prostate basal cells repair the luminal compartment by undergoing differentiation into intermediate cells and then luminal cells, as suggested by the increase in luminal proliferation after basal proliferation.

Discussion {#sec3}
==========

Our studies have shown that E-cadherin plays an essential role in the maintenance of prostate epithelial integrity and are consistent with the requirement for E-cadherin in homeostasis of other epithelial tissues. For example, deletion of E-cadherin in the mouse small intestine and uterus in vivo leads to increased apoptosis and abnormal differentiation, underscoring its essential role in maintenance of epithelial architecture and function ([@bib24], [@bib26]). Similarly, we have found that deletion of E-cadherin in prostate luminal cells results in their sloughing into the prostate lumen followed by anoikis. After loss of luminal cells, the prostate epithelium is repaired by the activity of basal progenitors, likely by differentiation through a transitional "intermediate cell" state, together with activated luminal progenitors.

Notably, this process of tissue repair differs from androgen-mediated regeneration of the regressed prostate, which is largely driven by unipotent luminal and basal progenitors, with contributions from bipotential luminal and basal stem/progenitor cells ([@bib6], [@bib21], [@bib22], [@bib38], [@bib39], [@bib42]). Such differences in progenitor behavior may reflect the severity of tissue "damage" ([Figure 4](#fig4){ref-type="fig"}). Overall, we propose that the identity of stem/progenitor cells depends upon the tissue context, and that there is no single cell population that can account for all stem cell properties within the prostate epithelium.

Unlike other known contexts in which adult prostate basal cells can generate luminal cells, the surrounding stromal tissue is not profoundly affected in our epithelial repair model. For example, basal-to-luminal differentiation occurs in sphere formation assays in the absence of stromal tissue, as well as in tissue recombinant grafts with heterologous inductive mesenchyme ([@bib4], [@bib11], [@bib12], [@bib13], [@bib18], [@bib25], [@bib39]). Furthermore, a model of bacterial prostatitis also displays acute inflammation and stromal reactivity, which was suggested to be responsible for altered basal cell properties ([@bib17]). These previous observations were consistent with the notion that the stroma represents an important niche for basal progenitors. In contrast, basal-to-luminal differentiation occurs in our E-cadherin deletion model when there is no alteration of the surrounding stroma, suggesting that there are signals intrinsic to the prostate epithelium that can promote basal cells to participate in tissue repair. It will be interesting in future studies to determine the identity of such signals that activate basal cell proliferation and differentiation.

Our findings potentially reconcile studies of prostate epithelial stem/progenitor activity with work on injury/repair models in other epithelial tissues ([@bib1]). For example, basal cells can form luminal secretory and ciliated cell types in the lung airway epithelium after treatment with noxious chemicals ([@bib14]), and basal cells in the bladder urothelium can generate intermediate and luminal umbrella cells after bacterial or chemical injury ([@bib30]). Thus, our findings contribute to a unifying perspective for a role of basal cells in injury repair of a range of epithelial tissues. Finally, we suggest that the inherent plasticity of prostate basal cells that can be observed in pathological conditions and in cancer reflects latent progenitor activity that normally functions in tissue repair.

Experimental Procedures {#sec4}
=======================

Mouse Procedures {#sec4.1}
----------------

Experiments using mice were performed according to protocols approved by the Institutional Animal Care and Use Committee at Columbia University Medical Center. The *Nkx3.1*^*CreERT2*^ allele was generated previously in our laboratory ([@bib38]), the *Cdh1*^*flox*^ allele was obtained from the Jackson Laboratory Induced Mutant Resource (B6.129-*Cdh1*^*tm2Kem*^/J) ([@bib3]), and the *R26R-YFP* reporter ([@bib31]) was kindly provided by Dr. Frank Costantini. For induction of Cre activity, tamoxifen (Sigma catalog \#T5648) dissolved in corn oil was introduced by oral gavage (40 mg/kg) for 4 consecutive days to mice at 2--3 months of age. See also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Histology and Immunostaining {#sec4.2}
----------------------------

Individual prostate lobes were fixed in 10% formalin followed by paraffin embedding, and immunostaining was performed on 5-μm sections. H&E staining was performed using standard protocols. See also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Quantitation and Statistical Analyses {#sec4.3}
-------------------------------------

For quantitation of immunofluorescence staining, 63× images from a Leica TCS2 AOBS spectral confocal microscope were used for manual counting of the number of cells with the indicated expression patterns. For statistical comparisons in [Figure 3](#fig3){ref-type="fig"}, percentages were analyzed by an unpaired t test or one-way ANOVA and Dunnett\'s multiple comparison test using Prism 6 software (GraphPad).
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![Inducible Deletion of E-Cadherin in the Prostate Epithelium\
(A) Schematic timeline of the experiment.\
(B--G) H&E staining of histological sections from the anterior prostate. Arrows in (C) show patches of atypical cells, and arrows in (D), (E), and inset in (E) show cells sloughing into the lumen in *Cdh1*^*del*^ prostates.\
(H--M) Immunofluorescence staining for E-cadherin and YFP. Arrows in (H) show intact E-cadherin expression in control mice; arrows in (I), (J), (K), and (M) show E-cadherin loss in YFP^+^ cells of *Cdh1*^*del*^ prostates; and arrows in (L) indicate rare YFP^+^ cells in which E-cadherin was not deleted.\
(N--S) Immunofluorescence staining for p120 catenin and YFP. Arrows in (O), (P), and (Q) show cytoplasmic p120 staining in YFP^+^ cells of *Cdh1*^*del*^ prostates.\
Numbers of mice examined: n = 7 for (B), (E), (H), (K), (N), and (Q); n = 5 for (C), (I), and (O); n = 4 for (D), (F), (G), (J), (L), (M), (P), (R), and (S). Scale bars, 50 μm. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}; [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Deletion of E-Cadherin in Prostate Luminal Cells Results in Anoikis without Reactive Stroma\
(A--C) Immunofluorescence staining of anterior prostate for CK18, E-cadherin, and YFP; arrows show CK18 expression in YFP^+^ cells.\
(D--F) Immunofluorescence staining for CK5, E-cadherin, and YFP; arrows show that YFP^+^ cells do not express CK5.\
(G--I) Immunofluorescence staining for CK18 and cleaved caspase-3 (CC3). The arrow in (H) shows co-localization of CC3 and CK18 in a sloughed cell; inset in (H) shows co-localization of CC3 (red) and YFP (green).\
(J--L) Immunohistochemical staining for smooth muscle α-actin shows normal appearance of smooth muscle in control and *Cdh1*^*del*^ prostates (arrows).\
(M--O) Immunohistochemical staining for vimentin shows nearly undetectable expression in control and *Cdh1*^*del*^ prostates.\
Numbers of mice examined: n = 3 for (A), (C), (D), (F), (G), (I), (J), (L), (M), and (O); n = 4 for (B), (E), (H), (K), and (N). Scale bars, 50 μm. See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Basal Cells Contribute to Epithelial Repair following E-Cadherin Deletion\
(A--F) Immunofluorescence staining for CK5 and CK8 identifies double-positive intermediate cells (arrows).\
(G--L) Immunofluorescence staining for CK8, CK5, and Ki67 shows low levels of proliferation in luminal (arrows) and basal (arrowheads) cells of control and *Cdh1*^*del*^ prostates.\
(M--O) Quantitation of the proportions of basal (M), luminal (N), and intermediate (O) cells in control and *Cdh1*^*del*^ prostates. Values represent the mean and SD of at least three animals per group.\
(P and Q) Quantitation of cell proliferation (P) and cell death (Q) in the basal and luminal compartments. Values represent the mean and SD (error bars) of at least three animals per group.\
Numbers of mice examined: n = 4 for (A), (B), (C), (E), (G), (H), (I), and (K); n = 5 for (D) and (J); n = 3 for (F) and (L). Scale bars, 50 μm. See also [Tables S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Assay Dependence of Stem/Progenitor Activity in the Prostate Epithelium\
Schematic depiction of tissue repair and androgen-mediation regeneration of the prostate epithelium; newly generated cells are indicated by different colors. During tissue repair, luminal epithelial cells are primarily generated by a process of basal proliferation and basal-to-luminal differentiation in which "intermediate" cells represent a transitional state; in addition, there is activity of unipotent luminal progenitors. During androgen-mediated regeneration, tissue growth is largely mediated by unipotent luminal and basal progenitors, with a significant contribution by bipotential luminal stem cells (castration-resistant Nkx3.1-expressing cells \[CARNs\]).](gr4){#fig4}
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